Assisting clients during the process of a Due Diligence for a new product, new opportunity or even an acquisition of a new company, taking into account the specific requirements in Europe.
Target clients: pharmaceutical companies, especially small and medium sized ones which are interested in taking over a product or running development for Europe or intend to co-operate with another company.
I provide you with the following customer services:
Cross-functional review (Quality, Clinical, Regulatory, IP, Market assessment) of generic and biotech R&D projects to help companies to initiate, accelerate or stop R&D activities
CMC, clinical and regulatory due diligence (incl. in- and out-sourcing of projects)
Due Diligence in course of a M&A process